In the MIROCALS trial, Gilbert Bensimon and colleagues1 showed that low-dose interleukin-2 (IL-2) added to riluzole did not significantly reduce mortality in an unadjusted analysis of patients with ...
We thank Yutaka Shimazu for his insightful comments. We agree that our positive findings1–4 highlight the urgent need for further work on biomarkers of neuronal damage and immune mechanisms in ...
The classic 4-4-2 featured box-to-box midfielders, who rampaged up and down the field, and strike partnerships up front: Alan ...
Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It's the ...
Total Operating Expenses: For Q3 2025, total operating expenses decreased $8.1 million, or 20%, compared with Q3 2024, due primarily to the impact of the June 2025 operational restructuring. Excluding ...
Among specific types of cancer, Australia spent the most on lung cancer and non-melanoma skin cancer ($1.87 billion each), ...
Despite how vital it is to our existence, most of us rarely think about our heartbeat until, say, a surge of adrenaline ...
CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...
Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...
The NFL wrapped up its Week 6 action with a "Monday Night Football" doubleheader, where the Atlanta Falcons beat the Buffalo Bills and the Chicago Bears earned a victory over the Washington Commanders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback